Cambridge, UK: o2h Ventures, a leading venture capital firm focused on seed stage investing into biotech therapeutics in the UK, is delighted to announce that it has been selected as a finalist for “Best Seed VC of the Year” by the prestigious UKBAA Angel Investment Awards 2023.
o2h Ventures is an early-stage biotech therapeutics fund that has seen many of its portfolio companies move into Series A and B investments, with three now moving through pivotal clinical studies in humans. We invests across the whole of the UK though 75% of its portfolio is based in Cambridge, UK. The team at o2h Ventures likes to be involved early and is either among the first investors or first institutional investors in 15 out of the 28 companies that they have invested in.
Sunil Shah, CEO at o2h Ventures, said, “Our qualification as a finalist for Best Seed VC by the UKBAA Awards is a testament to our passion for driving innovation in the biotech sector and supporting entrepreneurs on their path to success. We take immense pride in our role as a catalyst for groundbreaking ideas and are honored to be recognized by the UKBAA for our commitment to nurturing early-stage biotech companies to develop new biotech therapeutics.
The UKBAA Awards 2023 ceremony, scheduled for 6th July 2023, will bring together key industry leaders, investors, and entrepreneurs to celebrate the exceptional achievements of the venture capital community.
To find out more about the awards: https://awards.ukbaa.org.uk/
About UKBAA Angel Investment Awards
The annual UKBAA Angel Investment Awards celebrate high growth and success of the angel and early-stage investment market – recognising the fastest growing brands and acknowledging the founders, angels, crowd funders and early-stage venture capital investors behind them.
The Awards ceremony is taking place at the Science Museum, London on Thursday 6th July 2023 at 7pm, and will showcase the success & determination of the angel and early-stage investment community